Search Tag: Long COVID

ICU Management

2024 09 Jun

  In a recent clinical trial, a 15-day course of nirmatrelvir-ritonavir targeting SARS-CoV-2 was found to be safe as an extended-duration treatment. However, it did not alleviate specific symptoms of long COVID. These findings are published in JAMA Internal Medicine.   The combination of nirmatrelvir-ritonavir is approved by the FDA for treating...Read more

ICU Management

2022 10 May

More than 500 million cases of COVID-19 have been reported worldwide. Patients infected with COVID-19 are at a higher risk of persisting health impairments six months after hospital discharge associated with reduced physical function and health and quality of life. It is thus important to understand the long-term trajectory of recovery from COVID-19....Read more

ICU Management

2022 12 Apr

COVID-19 has had a significant impact on the number of hospital admissions, including many patients presenting acute respiratory failure. Approximately 15% of hospitalised COVID-19 patients require ICU admission.  It is well established that the physical and psychological impact of an ICU stay on patients can be quite significant and prolonged....Read more